Physician profile
Veronica I Matticks
NPI 1548706708
$3,672.20
in general payments reported to CMS, 2019-2025
17 companies · $1,101 in 2025
The $1,101 reported for 2025 was more than what 88% of Acute Care (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $137).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $276 · 2022: $524 · 2023: $832 · 2024: $939 · 2025: $1,101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,871.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,241.81 | 2021-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $618.94 | 2021-2025 | Lifevest |
| Cvrx, INC. | $391.86 | 2024-2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.61 | 2022-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $292.18 | 2021-2025 | Farxiga, Brilinta, Wainua |
| Novartis Pharmaceuticals Corporation | $220.93 | 2021-2023 | |
| Edwards Lifesciences Corporation | $133.20 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Merck Sharp & Dohme LLC | $106.29 | 2023-2025 | Verquvo |
| Boston Scientific Corporation | $67.07 | 2021-2024 | Eluvia |
| Scpharmaceuticals INC. | $45.07 | 2025 | |
| Impulse Dynamics (USA) INC. | $40.84 | 2024-2025 | Optimizer |
| Glaxosmithkline, LLC. | $40.53 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $32.51 | 2021-2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $30.61 | 2021 | |
| Mannkind Corporation | $28.19 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $25.18 | 2021 | |
| Lantheus Medical Imaging, INC. | $19.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veronica Matticks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.